Literature DB >> 11124110

The Th1-Th2 classification of cellular immune responses: concepts, current thinking and applications in haematological malignancy.

M B Lappin1, J D Campbell.   

Abstract

The finding that T cell immune responses could be divided into those promoting cell mediated immunity (Th1) and humoral responses (Th2) has had a profound effect on the understanding of immune response generation over the last 15 years. With ever increasing knowledge of the immune system, the model has come under criticism, as not all responses easily fit the classification. Nonetheless, the model still provides a valuable framework on which to base immunological research. In this review we update the model with current thinking regarding the generation and maintenance of immune responses. We then examine how the Th1-Th2 paradigm may be applied in developing new understanding of several topical issues in haematological malignancy-control of graft-versus-host disease; cytokine control of proliferating clones in B and T cell diseases; and suppression of T cell responses in multiple myeloma. Copyright 2000 Harcourt Publishers Ltd.

Entities:  

Mesh:

Year:  2000        PMID: 11124110     DOI: 10.1054/blre.2000.0136

Source DB:  PubMed          Journal:  Blood Rev        ISSN: 0268-960X            Impact factor:   8.250


  10 in total

1.  Chitosan-modified cobalt oxide nanoparticles stimulate TNF-α-mediated apoptosis in human leukemic cells.

Authors:  Sourav Chattopadhyay; Sandeep Kumar Dash; Santanu Kar Mahapatra; Satyajit Tripathy; Totan Ghosh; Balaram Das; Debasis Das; Panchanan Pramanik; Somenath Roy
Journal:  J Biol Inorg Chem       Date:  2014-01-21       Impact factor: 3.358

Review 2.  Zinc oxide nanoparticles for selective destruction of tumor cells and potential for drug delivery applications.

Authors:  John W Rasmussen; Ezequiel Martinez; Panagiota Louka; Denise G Wingett
Journal:  Expert Opin Drug Deliv       Date:  2010-09       Impact factor: 6.648

3.  Anticancer and immunostimulatory role of encapsulated tumor antigen containing cobalt oxide nanoparticles.

Authors:  Sourav Chattopadhyay; Sandeep Kumar Dash; Totan Ghosh; Sabyasachi Das; Satyajit Tripathy; Debasis Mandal; Debasis Das; Panchanan Pramanik; Somenath Roy
Journal:  J Biol Inorg Chem       Date:  2013-09-17       Impact factor: 3.358

4.  The Influences of Cell Type and ZnO Nanoparticle Size on Immune Cell Cytotoxicity and Cytokine Induction.

Authors:  Cory Hanley; Aaron Thurber; Charles Hanna; Alex Punnoose; Jianhui Zhang; Denise G Wingett
Journal:  Nanoscale Res Lett       Date:  2009-09-16       Impact factor: 4.703

5.  Immunomodulatory drugs suppress Th1-inducing ability of dendritic cells but enhance Th2-mediated allergic responses.

Authors:  Vien Phan; Tomoki Ito; Muneo Inaba; Yoshiko Azuma; Kayoko Kibata; Noriko Inagaki-Katashiba; Akihiro Tanaka; Atsushi Satake; Shosaku Nomura
Journal:  Blood Adv       Date:  2020-08-11

6.  Moderate aerobic exercise alters migration patterns of antigen specific T helper cells within an asthmatic lung.

Authors:  Kari J Dugger; Taylor Chrisman; Ben Jones; Parker Chastain; Kacie Watson; Kim Estell; Kurt Zinn; Lisa Schwiebert
Journal:  Brain Behav Immun       Date:  2013-08-06       Impact factor: 7.217

Review 7.  Aging and the dendritic cell system: implications for cancer.

Authors:  Michael R Shurin; Galina V Shurin; Gurkamal S Chatta
Journal:  Crit Rev Oncol Hematol       Date:  2007-04-18       Impact factor: 6.312

8.  Nanovaccine Confers Dual Protection Against Influenza A Virus And Porcine Circovirus Type 2.

Authors:  Peiyang Ding; Qianyue Jin; Xinxin Chen; Suzhen Yang; Junqing Guo; Guangxu Xing; Ruiguang Deng; Aiping Wang; Gaiping Zhang
Journal:  Int J Nanomedicine       Date:  2019-09-16

9.  Immunosuppressive effects of radiation on human dendritic cells: reduced IL-12 production on activation and impairment of naive T-cell priming.

Authors:  A Merrick; F Errington; K Milward; D O'Donnell; K Harrington; A Bateman; H Pandha; R Vile; E Morrison; P Selby; A Melcher
Journal:  Br J Cancer       Date:  2005-04-25       Impact factor: 7.640

10.  PRR15 Is a Novel Diagnostic and Prognostic Biomarker in Papillary Thyroid Cancer and Modulates the Tumor Microenvironment.

Authors:  Lingli Wang; Xiaoqing Deng; Yi Chen; Yixia Zhao; Zhirong Li
Journal:  J Oncol       Date:  2022-09-15       Impact factor: 4.501

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.